Yakar, S
The study did, however, also highlighted several negative side effects, including constipation (118 occurrences), diarrhea (100 events), and abdominal pain (41 events per 1,000) ( Abdominal pain, nausea, vomiting, and diarrhea are among the gastrointestinal adverse effects linked to GLP-1 RAs
Retatrutide is the first to activate all three GLP-1, GIP and glucagon
In other words
Wegovy manufacturer Novo Nordisk designed this medication as a once weekly subcutaneous injection on the upper arm, thigh or stomach with gradual dosing escalation to allow the body to adjust to the medication
Custom programs tailored to your unique needs Physician-directed plans for safe, effective results Knowledgeable and friendly staff dedicated to your success Here Is How The Program Works Our systematic approach ensures that your weight loss is safe, effective, and sustainable